Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with cystic fibrosis who are taking a CFTR modulator medication (either Ivacaftor alone, or Ivacaftor combined with Lumacaftor)
- People with cystic fibrosis who are not taking any CFTR modulator medication
- People who were thought to possibly have cystic fibrosis, but where tests (physical and genetic) ruled it out
Who may not be able to join:
- Women who are pregnant or currently breastfeeding
- People for whom a nasal swab procedure would not be safe or suitable (confirm with trial site)
- People for whom a rectal biopsy procedure would not be safe or suitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aleksander Edelman, phD, APHP
Phone: 33 1 44 49 48 87
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Forced Expiratory Volume in 1 second
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.